Beyond market trends, investors keen on maximizing returns delve into the world of stock picking. The right selections can be instrumental in catapulting your wealth.
After finishing at $7.77 in the prior trading day, Sage Therapeutics Inc (NASDAQ: SAGE) closed at $7.60, down -2.19%. In other words, the price has decreased by -$2.19 from its previous closing price. On the day, 1.02 million shares were traded.
Ratios:
Our goal is to gain a better understanding of SAGE by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.42 and its Current Ratio is at 7.42. In the meantime, Its Debt-to-Equity ratio is 0.03 whereas as Long-Term Debt/Eq ratio is at 0.02.
On November 21, 2024, RBC Capital Mkts Upgraded its rating to Sector Perform which previously was Underperform but kept the price unchanged to $4.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 10 ’24 when JONAS JEFFREY M bought 7,500 shares for $5.53 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 11.54 while its Price-to-Book (P/B) ratio in mrq is 1.00.
Stock Price History:
Over the past 52 weeks, SAGE has reached a high of $14.71, while it has fallen to a 52-week low of $4.62. The 50-Day Moving Average of the stock is 0.57%, while the 200-Day Moving Average is calculated to be 3.02%.
Shares Statistics:
A total of 61.36M shares are outstanding, with a floating share count of 54.08M. Insiders hold about 12.03% of the company’s shares, while institutions hold 82.52% stake in the company.
